Today’s Daily Telegraph features an interview with a female tennis player who served a ban for a positive drug test and made her comeback at the indoor clay event in Stuttgart. No it’s not the one you’re thinking of (I’ll get to her later…).
The player I’m talking about is Barbora Strycova the World number 20 from the Czech Republic. Strycova is a member of the successful Czech Fed Cup team who have won the Fed Cup in five of the last six years. Not as famous as her compatriots Petra Kvitova and Karolina Pliskova she was still an important part of the team and in the last two years she played in the final decisive doubles rubber which clinched the title for the Czechs.
But she wasn’t always as highly regarded. In 2012 she tested positive for the banned stimulant sibultramine as a result of consuming a dubious weight-loss supplement called Acai Berry Thin. On April 22 2013 she made her comeback in the first qualifying round of Stuttgart (I’ve emphasised qualifying quite deliberately) losing to Mirjana Lucic-Baroni. After Stuttgart she played in a humble $25,000 ITF tournament in Wiesbaden Germany which is the lowest level of the women’s professional game. She lost in her first match. She had to qualify for all the Grand Slams – two of them successfully – and play more ITF tournaments. She was given no favours which having served a drug ban she should not have been. But to her credit she grafted and at the end of 2013 she had got back into the World’s top 100.
Four years later, on April 26 2017 another female tennis player will make her comeback from a drugs ban – a fifteen month drugs ban. This is of course Maria Sharapova. Sharapova like Strycova will make her comeback in Stuttgart. But that is where the similarity ends. First of all the tournament starts on April 24 but Sharapova’s ban ends on the 26th. But shamefully Sharapova will be allowed to play in Stuttgart despite this and she will be given the right to start on the 26th – a Wednesday – while players like Strycova who will be playing for the Czech Republic in the USA the week before – have to start on Monday or Tuesday.
Even worse Sharapova has been given a wildcard straight into the first round of Stuttgart. And not only Stuttgart. She has also been given wildcards into the first round of the Madrid Open and the Rome Masters. Remember Strycova had to start in the qualifying of Stuttgart and play humble ITF events. Why shouldn’t Sharapova? After all she failed a drug test too and her ban was longer than Strycova’s.
I should stress I’m not blaming the tournaments in question as Sharapova is a draw and the tournaments are out for their own interests. I am blaming the Women’s Tennis Association (WTA). This gutless spineless excuse for a governing body should make sure all players are treated equally. If Strycova had to start in the qualifying round of big tournaments and in humble ITF events so should Sharapova. So should anyone who fails a drug test. Now if a player is a victim of a stabbing (like poor Petra Kvitova was before Christmas) or if a player falls pregnant and has a child (as Victoria Azarenka did last year) they are fully entitled to wildcards and having their ranking protected. But a player who failed a drugs test should not be given preferential treatment either to clean players or to other players who failed drug tests.
Hopefully the Grand Slams behave differently. Sharapova will definitely either have to qualify for the French Open or rely on a wild card. She might have to do likewise for Wimbledon if she has not accumulated around 600 ranking points by May 22. The French Open and Wimbledon must NOT reward a player who failed a drug test. Sharapova is entitled to attempt a comeback. But the French Open and Wimbledon must do what the WTA did not have the guts to do. They must not give her a wildcard. Sharapova and all other drug test failures should be told they must restart at the bottom. Just like Barbora Strycova had to…